Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Longevity Acquisition Corp (LOAC)

Longevity Acquisition Corp (LOAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
4D pharma Announces Completion of Merger With Longevity Acquisition Corporation

4D pharma plc (Nasdaq: LBPS; AIM: DDDD) ("4D pharma" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma Announces Private Placement

4D pharma plc (AIM: DDDD) ("4D" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma to Present at Upcoming Investor Conferences in March

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announced that 4D management...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management Team

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the appointment of...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces that the United...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D pharma Announces Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate MRx0518 in Combination with BAVENCIO® for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced a clinical trial...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
4D Pharma Presents Update on Oncology Program

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces progress on activities...

DDDD.LN : 16.660 (unch)
LOAC : 13.45 (+1.89%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SNSS, LOAC, FBSS, and CPAH Mergers

WILMINGTON, Del., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

SNSS : 18.62 (+24.30%)
LOAC : 13.45 (+1.89%)
FBSS : 21.28 (+0.47%)
CPAH : 3.48 (+0.43%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of ELY, LOAC, ROCH, and NGA Mergers

WILMINGTON, Del., Dec. 17, 2020 (GLOBE NEWSWIRE) --

ELY : 21.33 (-2.82%)
LOAC : 13.45 (+1.89%)
ROCH : 28.90 (+12.23%)
NGA : 16.17 (-6.53%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Longevity Acquisition Corporation Merger

WILMINGTON, Del., Dec. 02, 2020 (GLOBE NEWSWIRE) --

LOAC : 13.45 (+1.89%)

Barchart Exclusives

Is Amazon Stock a Buy? Here’s What Investors Need to Know Now
Amazon is doubling down on key growth areas that could drive further stock gains in the future. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar